Triple Therapy with Exenatide/Pioglitazone/Metformin vs. Conventional Therapy: Changes in Liver Fibrosis Scores after 2 Years of Treatment in Patients with New-Onset Type 2 Diabetes Mellitus

Authors :: Curtiss Puckett
Mariam Alatrach
Olga Lavrynenko
John S. Adams
Ralph A. DeFronzo
Naim Alkhouri
Muhammad A. Abdul-Ghani
Source :: Metabolism. 104:154111
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: medicine.medical_specialty
business.industry
Endocrinology, Diabetes and Metabolism
Liver fibrosis
Type 2 Diabetes Mellitus
Gastroenterology
New onset
Endocrinology
Internal medicine
Medicine
In patient
business
Pioglitazone/Metformin
Exenatide
medicine.drug

Tools